Advaxis and Sellas Life Sciences Group, two companies that have pursued different ways of prompting the body’s immune system to fight cancer, are now hoping that combining their efforts will lead to a more precise treatment. The agreement between the companies calls for Princeton, NJ-based Advaxis (NASDAQ: ADXS) to license to Sellas its technology for […]
What Our Clients Say
[ssba_hide]
[testimonials category="Testimonial" random=true limit="1"]
Press Releases and Whitepapers
Industry News & Articles
- AI inference startup Baseten reportedly raising $1.5B months after its last mega round
- Snap spins off AI video team into new company, Dotmo, due to costs
- OpenAI is bringing on some big guns in the lead-up to its IPO
- The 11 standout startups from YC’s Demo Day, according to VCs
- Almost half of U.S. singles feel negatively about AI in dating, Match says
- Amazon hopes to challenge Nvidia more directly by selling its AI chips
- Rivian owners file lawsuit alleging false promises on self-driving features
- Mivo’s new app takes a mindful approach to managing screen time
Sample Relationships
[logo-carousel id=relationships]
Notables
[logo-carousel id=notables]